The Media Database That Really Understands Journalists

Explore Our Database And See What Journalists Create So You Can Better Connect 🫶

Find Out More

Media Database B bloomberg.com Robert Langreth

Robert Langreth

Science and health reporter at large, Bloomberg News

Topics
appointments and personnel changes, biologics research, biotech, business, coronavirus, corporate officers, drug approval process, drug pricing, drugs, franchise: the-big-take, health, health news, health reporters, healthcare, healthcare journalists, industries, media, negotiated acquisitions, new drug applications, news, page: graphic, pharma, pharmaceutical research and development, pharmaceuticals, region: global, reporters, secondary brand: business, secondary brand: industries, vaccines
Recent articles
Gilead Sees 2026 Loss on $11.5 Billion in Deal-Related Costs (1)
May 07, 2026
news.bloomberglaw.com
J&J Sales Beat Expectations on Strong Cancer Medicine Growth
Apr 14, 2026
bloomberg.com
Lilly’s $7.8 Billion Bet Takes It Beyond Obesity Into Sleep
Apr 01, 2026
bloomberg.com
New Study Tests Vaccine’s Potential to Block Fentanyl’s Deadly Effects
Mar 31, 2026
bloomberg.com
Gilead to Buy Ouro Medicines for Its Autoimmune Drugs (2)
Mar 23, 2026
news.bloomberglaw.com
Gilead Nears Deal to Buy Ouro Medicines for Its Autoimmune Drugs
Mar 23, 2026
bloomberg.com
Key US Senator Investigates FDA Over Rare-Disease Drug Denials
Mar 10, 2026
news.bloomberglaw.com
FDA Investigated Over Rare-Disease Drug Denials by Senator
Mar 10, 2026
bloomberg.com
「官僚的な不条理」米議員がFDA批判-希少疾患薬の却下巡り調査開始
Mar 10, 2026
bloomberg.com
Sarepta CEO to Retire by Year-End to Spend Time With Sick Family
Feb 26, 2026
bloomberg.com

Find out everything there is to know

Publication resume, most loved topics, and more. Find out everything there is to know about a journalist, in our 500k+ database.

Start a free trial of BuzzSumo.

START YOUR FREE TRIAL

Already registered? Log in to your account